Satellos Completes Enrollment for Phase 1 SAT-3247 Trial in Healthy Volunteers Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF), a biotech company focused on developing small molecule therapies to treat muscle…
Orca-T® Hits Primary Endpoint in Precision-T Phase 3 Study for Hematologic Cancers Orca Bio, a late-stage biotechnology company focused on revolutionizing patient care through advanced cell therapies, today announced it…
Santhera Announces Catherine Isted as New CFO Santhera Pharmaceuticals (SIX: SANN) has announced the appointment of Catherine Isted as the company’s new Chief Financial Officer (CFO), effective February 24, 2025.…
PHC and CCRM Partner to Develop T-Cell Expansion Processes for Enhanced Efficiency and Quality PHC Corporation has entered into a Master Collaboration Agreement with CCRM to develop primary T-cell expansion…
Results from AceLink’s Phase 2 AL01211 Study in Fabry Disease Presented at WORLD Symposium 2025 AceLink Therapeutics, a clinical-stage biotech firm focused on developing next-generation oral substrate reduction therapies (SRTs),…
Crown Laboratories Finalizes Acquisition of Revance Therapeutics Crown Laboratories, Inc., a global leader in innovative skincare solutions and a part of the Hildred Capital portfolio, has officially closed its acquisition…
Cyclo Therapeutics Presents Positive Phase 3 TransportNPC™ Data in Children Under 3 Cyclo Therapeutics, Inc. (Nasdaq: CYTH), a clinical-stage biotechnology company focused on developing life-changing treatments for patients with rare…
Transplant of Genetically Engineered Porcine Kidney Successfully Performed in Second Patient by eGenesis eGenesis, a biotechnology firm focused on developing human-compatible engineered organs to help alleviate the global organ shortage,…
Webinar on Ataxia-Telangiectasia Unmet Need Hosted by Quince Therapeutics Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company focused on advancing treatments for rare diseases, has announced that it will…
Nephritis in Active Lupus: Gazyva’s Superiority Proven in NEJM Dat Genentech, a member of the Roche Group, announced that a detailed analysis of its Phase III REGENCY trial of Gazyva®…
Culina Health Earns Spot on 2025 New York Digital Health 100 List, Recognized for Innovation in Nutrition Care Culina Health, a pioneering telehealth platform dedicated to transforming access to clinical…
Blood Sensor Inspira Technologies Advances AI-Powered Blood Sensor, Eyes Clinical Milestones Future Markets Research has released an update highlighting recent developments from Inspira Technologies a company at the forefront of…